Abstract
Establishing causal relationships between environmental exposures and common diseases is beset with problems of unresolved confounding, reverse causation and selection bias that may result in spurious inferences. Mendelian randomization, in which a functional genetic variant acts as a proxy for an environmental exposure, provides a means of overcoming these problems as the inheritance of genetic variants is independent of—that is randomized with respect to—the inheritance of other traits, according to Mendel’s law of independent assortment. Examples drawn from exposures and outcomes as diverse as milk and osteoporosis, alcohol and coronary heart disease, sheep dip and farm workers’ compensation neurosis, folate and neural tube defects are used to illustrate the applications of Mendelian randomization approaches in assessing potential environmental causes of disease. As with all genetic epidemiology studies there are problems associated with the need for large sample sizes, the non-replication of findings, and the lack of relevant functional genetic variants. In addition to these problems, Mendelian randomization findings may be confounded by other genetic variants in linkage disequilibrium with the variant under study, or by population stratification. Furthermore, pleiotropy of effect of a genetic variant may result in null associations, as may canalisation of genetic effects. If correctly conducted and carefully interpreted, Mendelian randomization studies can provide useful evidence to support or reject causal hypotheses linking environmental exposures to common diseases.
Similar content being viewed by others
References
Al-Delaimy WK, Rexrode KM, Hu FB, Albert CM, Stampfer MJ, Willett WC, Manson JE (2004) Folate intake and risk of stroke among women. Stroke 35:1259–1263
Ames BN (1999) Cancer prevention and diet: help from single nucleotide polymorphisms. PNAS 96:12216–12218
Baird P (2000) Genetic technologies and achieving health for populations. Int J Health Serv 30:407–24
Baron DN, Dent CE, Harris H, Hart EW, Jepson JB (1956) Hereditary pellagra-like skin rash with temporary cerebellar ataxia, constant renal amino-aciduria, and other bizarre biochemical features. Lancet 271:421–429
Baron JA, Cole BF, Sandler RS et al (2003) A randomized trial of aspirin to prevent colorectal adenomas. N Eng J Med 348:891–899
Bautista LE, Smeeth L, Hingorani AD, Casas JP (2006) Estimation of bias in nongenetic observational studies using “Mendelian Triangulation”. Ann Epidemiol 16:675–680
Bazzano LA, Reynolds K, Holder KN, He J (2006) Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. JAMA 296:2720–2726
Berkowitz A (1999) Our genes, ourselves?. Bioscience 46:42–51
Berkson J (1946) Limitations of the application of fourfold table analysis to hospital data. Biometrics Bull 2:47–53
Bhatti P, Sigurdson AJ, Wang SS, Chen J, Rothman N, Hartge P, Bergen AW, Landi MT (2005) Genetic variation and willingness to participate in epidemiological research: data from three studies. Cancer Epidemiol Biomarkers Prev 14:2449–2453
Birge SJ, Keutmann HT, Cuatrecasas P, Whedon GD (1967) Osteoporosis, intestinal lactase deficiency and low dietary calcium intake. N Engl J Med 276:445–448
Bochud M, Chiolero A, Elston RC, Paccaud F (2007) A cautionary note on the use of Mendelian randomization to infer causation in observational epidemiology. Int J Epidemiol. doi:10.1093/ije/dym186
Botto LD, Yang Q (2000) 5, 10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol 151:862–877
Brennan P (2002) Gene environment interaction and aetiology of cancer: what does it mean and how can we measure it? Carcinogenesis 23(3):381–387
Brennan P (2004) Mendelian randomization and gene–environment interaction. Int J Epidemiol 33:17–21
Broer S, Cavanaugh JA, Rasko JEJ (2004) Neutral amino acid transport in epithelial cells and its malfunction in Hartnup disorder. Transporters 33:233–236
Brown MS, Goldstein JL (2006) Lowering LDL—not only how low, but how long? Science 311:1721–1723
Casas JP, Shah T, Cooper J, Hawe E, McMahon AD, Gaffney D, et al (2006) Insight into the nature of the CRP-coronary event association using Mendelian randomization. Int J Epidemiol 35:922–931
Chao Y-C, Liou S-R, Chung Y-Y, Tang H-S, Hsu C-T, Li T-K, Yin S-J (1994) Polymorphism of alcohol and aldehyde dehydrogenase genes and alcoholic cirrhosis in Chinese patients. Hepatology 19:360–366
Cherry N, Mackness M, Durrington P et al (2002) Paraoxonase (PON1) polymorphisms in farmers attributing ill health to sheep dip. Lancet 359:763–764
Cheverud JM (1988) A comparison of genetic and phenotypic correlations. Evolution 42:958–968
Clayton D, McKeigue PM (2001) Epidemiological methods for studying genes and environmental factors in complex diseases. Lancet 358:1356–1360
Cohen JC, Boerwinkle E, Mosely TH, Hobbs HH (2006) Sequence variations in PSCK9, low LDL, and protection against coronary heart disease. N Engl J Med 354:1264–1272
Collins FS (1999) Medical and societal consequences of the Human Genome Project. N Engl J Med 341:28–37
Corazza GR, Benati G, Di Sario A et al (1995) Lactose intolerance and bone mass in postmenopausal Italian women. Br J Nutr 73:479–487
Correns CG (1900) Mendel’s Regel über das Verhalten der Nachkommenschaft der Bastarde. Berichte der Deutschen Botanischen Gesellschaft 8:158–68. English translation, G. Mendel’s law concerning the behavior of progeny of varietal hybrids. In: Stern and Sherwood, pp 119–32. WH Freeman and Co., San Francisco (1966)
Czeizel AE, Dudás I (1992) Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 327:1832–1835
Davey Smith G (2006) Cochrane lecture: randomised by (your) god: robust inference from an observational study design. J Epidemiol Community Health 60:382–388
Davey Smith G (2007) Capitalising on Mendelian randomization to assess the effects of treatments. J R Soc Med 100:432–435
Davey Smith G, Ebrahim S (2002) Data dredging, bias, or confounding (editorial). BMJ 325:1437–1438
Davey Smith G, Ebrahim S (2003) ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 32:1–22
Davey Smith G, Ebrahim S (2004) Mendelian randomization: prospects, potentials, and limitations. Int J Epidemiol 33:30–42
Davey Smith G, Ebrahim S (2005a) What can Mendelian randomization tell us about modifiable behavioural and environmental exposures. BMJ 330:1076–1079
Davey Smith G, Ebrahim S (2005b) Folate supplementation and cardiovascular disease. Lancet 366:1679–1681
Davey Smith G, Ebrahim S (2007) Mendelian randomization: genetic variants as instruments for strengthening causal inference in observational studies. In: Vaupel JW, Weinstein M (eds) Bio-social surveys: current insight and future promise. The National Academies Press, National Research Council, Washington, DC
Davey Smith G, Phillips AN (1996) Inflation in epidemiology: ‘The proof and measurement of association between two things’ revisited. Br Med J 312:1659–1661
Davey Smith G, Harbord R, Ebrahim S (2004) Fibrinogen, C-reactive protein and coronary heart disease: does Mendelian randomization suggest the associations are non-causal? Q J Med 97:163–166
Davey Smith G, Ebrahim S, Lewis S, Hansell A, Palmer LJ, Burton P (2005a) Genetic epidemiology and public health: hope, hype, and future prospects. Lancet 366:1484–1498
Davey Smith G, Lawlor D, Harbord R, Timpson N, Rumley A, Lowe G, Day I, Ebrahim S (2005b) Association of C-reactive protein with blood pressure and hypertension: lifecourse confounding and Mendelian randomization tests of causality. Arterioscler Thromb Vasc Biol 25:1051–1056
Davey Smith G, Harbord R, Milton J, Ebrahim S, Sterne JAC (2005c) Does elevated plasma fibrinogen increase the risk of coronary heart disease?: evidence from a meta-analysis of Genetic Association Studies. Arterioscler Thromb Vasc Biol 25:2228–2233
Davey Smith G, Lawlor D, Harbord R, Timpson N, Day I, Ebrahim S (2007) Clustered environments and randomized genes: a fundamental distinction between conventional and genetic epidemiology. PLoS Medicine (in press)
Elwood PC, Yarnell JWG, Burr ML et al (1991) Epidemiological studies of cardiovascular disease: progress report VII. MRC Epidemiology Unit, Cardiff
Enomoto N, Takase S, Yasuhara M, Takada A (1991) Acetaldehyde metabolism in different aldehyde dehydrogenase-2 genotypes. Alcohol Clin Exp Res 15:141–144
Færgeman O (2003) Coronary artery disease: genes drugs and the agricultural connection. Elseveir, Netherlands
Fallon UB, Ben-Shlomo Y, Davey Smith G (2001) Homocysteine and coronary heart disease. Heart Online, March 14th. http://heart.bmjjournals.com/cgi/eletters/85/2/153
Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM et al (2007) A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316:889–894
Gause GF (1942) The relation of adaptability to adaption. Q Rev Biol 17:99–114
Goldschmidt RB (1938) Physiological genetics. McGraw-Hill, New York
Gray R, Wheatley K (1991) How to avoid bias when comparing bone marrow transplantation with chemotherapy. Bone Marrow Transplant 7(suppl 3):9–12
Gutjahr E, Gmel G, Rehm J (2001) Relation between average alcohol consumption and disease: an overview. Eur Addict Res 7:117–27
Guy JT (1993) Oral manifestations of systematic disease. In: Cummings CW et al (eds) Otolaryngology—head and neck surgery, vol 2. Mosby, St Louis
Hart C, Davey Smith G, Hole D, Hawthorne V (1999) Alcohol consumption and mortality from all causes, coronary heart disease, and stroke: results from a prospective cohort study of Scottish men with 21 years of follow up. Br Med J 318:1725–1729
Hasin D, Aharonovich E, Liu X, Mamman Z, Matseoane K, Carr L, Li TK (2002) Alcohol and ADH2 in Israel: Ashkenazis, Sephardics, and recent Russian immigrants. Am J Psychiatry 159:1432–1434
He K, Merchant A, Rimm EB, Rosner BA, Stampfer MJ, Willett WC, Ascherio A (2004) Folate, vitamin B6, and B12 intakes in relation to risk of stroke among men. Stroke 35:169–174
Heart Protection Study Collaborative Group (writing committee: Collins R, Armitage J, Parish S, Sleight, Peto R) (2002) MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high risk individuals: a randomised placebo-controlled trial. Lancet 360:7–22
Higuchi S, Matsuushita S, Imazeki H, Kinoshita T, Takagi S, Kono H (1994) Aldehyde dehydrogenase genotypes in Japanese alcoholics. Lancet 343:741–742
Hingorani A, Humphries S (2005) Nature’s randomised trials. Lancet 366:1906–1908
Holtzman NA (2001) Putting the search for genes in perspective. Int J Health Serv 31:445
Honkanen R, Pulkkinen P, Järvinen R, Kröger H, Lindstedt K, Tuppurainen M, Uusitupa M (1996) Does lactose intolerance predispose to low bone density? A population-based study of perimenopausal Finnish women. Bone 19:23–28
Honkanen R, Kröger H, Alhava E, Turpeinen P, Tuppurainen M, Saarikoski S (1997) Lactose intolerance associated with fractures of weight-bearing bones in Finnish Women aged 38–57 years. Bone 21:473–477
Hyppönen E, Davey Smith G, Power C (2007) Vitamin D status and self-perceived health: conventional and Mendelian randomisation approaches. J Epidemiol Community Health 61(suppl1):A14
Jablonka-Tavory E (1982) Genocopies and the evolution of interdependence. Evol Theory 6:167–170
Jousilahti P, Salomaa V (2004) Fibrinogen, social position, and Mendelian randomisation. J Epidemiol Community Health 58:883
Juul K, Tybjaerg-Hansen A, Marklund S, Heegaard NHH, Steffensen R, Sillesen H, Jensen G, Nordestgaard BG (2004) Genetically reduced antioxidative protection and increased ischaemic heart disease risk: the Copenhagen city heart study. Circulation 109:59–65
Katan MB (1986) Apoliopoprotein E isoforms, serum cholesterol, and cancer. Lancet I:507–508 (reprinted IJE 2004;34:9)
Keavney B (2002) Genetic epidemiological studies of coronary heart disease. Int J Epidemiol 31:730–736
Kelada SN, Eaton DL, Wang SS, Rothman NR, Khoury MJ (2003) The role of genetic polymorphisms in environmental health. Environ Health Perspect 111:1055–1064
Khoury M, Beaty TH, Cohen BH (1993) Fundamentals of genetic epidemiology. Oxford University Press, Oxford, p 13, 126
Khoury M, Little J, Burke W (2004) Human genome epidemiology. Oxford University Press, Oxford
Khoury M, Davis R, Gwinn M, Lindegren ML, Yoon P (2005) Do we need genomic research for the prevention of common diseases with environmental causes? Am J Epidemiol 161:799–805
Khoury MJ, Little J, Gwinn M, Ioannidis JPA (2007) On the synthesis and interpretation of consistent but weak gene–disease association studies in the era of genome-wide association studies. Int J Epidemiol 36:439–445
Kivimäki M, Lawlor DA, Davey Smith G, Eklund C, Murme M, Lehtimäki T, Viikari JS, Raitakari OT (2007) Variants in the CRP Gene as a measure of lifelong differences in average C-reactive protein levels. The cardiovascular risk in young Finns study, 1980–2001. Am J Epidemiol 166:760–764
Kraut JA, Sachs G (2005) Hartnup disorder: unravelling the mystery. Trends Pharmacol Sci 26:53–55
Kune GA, Kune S, Watson LF (1988) Colorectal cancer risk, chronic illnesses, operations and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Res 48:4399–4404
Lawlor DA, Harbord R, Sterne JAC, Timpson N, Davey Smith G (2007) Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stats Med. doi: 10.1002/sim.3034
Lawlor DA, Davey Smith G, Bruckdorfer KR et al (2004) Those confounded vitamins: what can we learn from the differences between observational versus randomised trial evidence? Lancet 363:1724–1727
LDL receptor mutation catalogue. http://www.ucl.ac.uk/fh. Accessed 16 Dec 2003
Leimar O, Hammerstein P, Van Dooren TJM (2006) A new perspective on developmental plasticity and the principles of adaptive morph determination. Am Nat 167:367–376
Lenz W (1973) Phenocopies. J Med Genet 10:34–48
Lewis S, Davey Smith G (2005) Alcohol, ALDH2 and esophageal cancer: a meta-analysis which illustrates the potentials and limitations of a Mendelian randomization approach. Cancer Epidemiol Biomarkers Prev 14:1967–1971
Lewis SJ, Ebrahim S, Davey Smith G (2005) Meta-analysis of MTHFR 677C->T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate? BMJ 331:1053
Li R, Tsaih SW, Shockley K, Stylianou IM, Wergedal J,Paigen B, Churchill GA (2006) Structural model analysis of multiple quantative traits. PLoS Genet 2:1046–1057
Lin HJ, Lakkides KM, Keku TO, Reddy ST, Louie AD et al (2002) Prostaglandin H Synthase 2 variant (Val511Ala) in African Americans may reduce the risk for colorectal neoplasia. Cancer Epidemiol Biomarkers Prev 11:1305–1315
Lipp HP, Schwegler H, Crusio WE, Wolfer DP, Leisinger-Trigona MC, Heimrich B, Driscoll P (1989) Using genetically-defined rodent strains for the identification of hippocampal traits relevant for two-way avoidance behaviour: a non-invasive approach. Experientia 45:845–859
Lower GM, Nilsson T, Nelson CE et al (1979) N-acetylransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Environ Health Perspect 29:71–79
Marks D, Thorogood M, Neil HAW, Humphries SE (2003) A review on diagnosis, natural history and treatment of familial hypercholesterolaemia. Atherosclerosis 168:1–14
McGrath J (1999) Hypothesis: is low prenatal vitamin D a risk-modifying factor for schizophrenia? Schizophr Res 40:173–177
McNamara JJ, Molot MA, Stremple JF, Cutting RT (1971) Coronary artery disease in combat casualties in Vietnam. JAMA 216:1185–1187
Meade TW, Humpries SE, De Stavola BL (2006) Commentary: fibrinogen and coronary heart disease—test of causality by “Mendelian” randomization by Keavney et al. Int J Epidemiol 35:944–947
Memik F (2003) Alcohol and esophageal cancer, is there an exaggerated accusation? Hepatogastroenterology 54:1953–1955
Mendel G (1866) Experiments in plant hybridization. http://www.mendelweb.org/archive/Mendel.Experiments.txt
Minelli C, Thompson JR, Tobin MD, Abrams KR (2004) An integrated approach to the meta-analysis of genetic association studies using Mendelian randomization. Am J Epidemiol 160:445–452
Morgan TH (1913) Heredity and sex. Columbia University Press, New York
Morgan TH (1918) Physical basis of heredity
MRC Vitamin Study Research Group (1991) Prevention of neural tube defects: results of the Medical Research Council vitamin study. Lancet 338:131–137
Myant NB (1993) Familial defective apolipoprotein B-100: a review, including some comparisons with familial hypercholesterolaemia. Atherosclerosis 104:1–18
Ness AR, Davey Smith G, Hart C (2001) Milk, coronary heart disease and mortality. J Epidemiol Community Health 55:379–382
Newcomer AD, Hodgson SF, Douglas MD, Thomas PJ (1978) Lactase deficiency: prevalence in osteoporosis. Ann Intern Med 89:218–220
Nitsch D, Molokhia M, Smeeth L, De Stavola B, Whittaker JC, Leon DA (2006) Limits to causal inference based on Mendelian randomization: a comparison with randomized controlled trials. Am J Epidemiol 163:397–403
Obermayer-Pietsch BM, Bonelli CM, Walter DE, Kuhn RJ, Fahrleitner-Pammer A, Berghold A, Goessler W, Stepan V, Dobnig H, Leb G, Renner W (2004) Genetic predisposition for adult lactose intolerance and relation to diet, bone density, and bone fractures. J Bone Miner Res 19:42–47
Olby RC (1966) Origins of Mendelism. Constable London
Palmer L, Cardon L (2005) Shaking the tree: mapping complex disease genes with linkage disequilibrium. Lancet 366:1223–1234
Peto R (1976) Two properties of multiple regression analysis and regression to the mean (and regression from the mean). In: Fletcher CM, Peto R, Tinker CM, Speizer FE (eds) The natural history of chronic bronchitis and emphysema: an eight year study of early chronic obstructive lung disease in working men in London. Oxford University Press, Oxford, pp 218–223
Reynolds K, Lewis LB, Nolen JDL, Kinney GL, Sathya B, He J (2003) Alcohol consumption and risk of stroke: a meta-analysis. JAMA 289:579–588
Roderic TH, Wimer RE, Wimer CC (1976) Genetic manipulation of neuroanatomical traits. In: Petrinovich L, McGaugh JL (eds) Knowing thinking and believing. Plenum, New York
Rose G (1982) Incubation period of coronary heart disease. BMJ 284:1600–1601
Rose S (1995) The rise of neurogenetic determinism. Nature 373:380–382
Rothman N, Wacholder S, Caporaso NE, Garcia-Closas M, Buetow K, Fraumeni JF (2001) The use of common genetic polymorphisms to enhance the epidemiologic study of environmental carcinogens. Biochim Biophys Acta 1471:C1–C10
Sandler RS, Galanko JC, Murray SC, Helm JF, Woosley JT (1998) Aspirin and nonsteroidal anti-inflammatory gents and risk for colorectal adenomas. Gastroenterology 114:441–447
Sandler RS, Halabi S, Baron JA et al (2003) A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 348:883–890
Scientific Steering Committee on behalf of the Simon Broome Register Group (1991) Risk of fatal coronary heart disease in familial hyper-cholesterolaemia. BMJ 303:893–896
Scriver CR (1988) Nutrient–gene interactions: the gene is not the disease and vice versa. Am J Clin Nutr 48:1505–1509
Scriver CR, Mahon B, Levy HL (1987) The Hartnup phenotypeL Mendelain transport disorder, multifactorial disease. Am J Hum Genet 40:401–412
Shaper AG, Wannamethee G, Walker M (1991) Milk, butter and heart disease. BMJ 302:785–786
Shepherd J, Cobbe SM, Ford I et al for the West of Scotland Coronary Prevention Study Group (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 333:1301–1307
Slack J (1969) Risks of ischaemic heart disease in familial hyperlipoproteinaemic states. Lancet 2:1380–1382
Snyder LH (1959) Fifty years of medical genetics. Science 129:7–13
Soria LF, Ludwig EH, Clarke HRG, Vega GL, Grundy SM, McCarthy BJ (1989) Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100. Proc Natl Acad Sci USA 86:587–591
Spearman C (1904) The proof and measurement of association between two things. Am J Psychol 15:72–101
Steinberg D (2004) Thematic review series: the pathogensis of athersclerosis. An interpretive history of the cholesterol controversy: part 1. J Lipid Res 45:1583–1593
Steinberg D (2005) Thematic review series: the pathogensis of athersclerosis. An interpretive history of the cholesterol controversy: part II: the early evidence linking hypercholestrolemia to cornary disease in humans. J Lipid Res 46:179–190
Strohman RC (1993) Ancient genomes, wise bodies, unhealthy people: the limits of a genetic paradigm in biology and medicine. Perspect Biol Med 37:112–145
Takagi S, Iwai N, Yamauchi R, Kojima S, Yasuno S, Baba T, Terashima M, Tsutsumi Y, Suzuki S, Morii I, Hanai S, Ono K, Baba S, Tomoike H, Kawamura A, Miyazaki S (2002) Aldehyde dehydrogenase 2 gene is a risk factor for myocardial infarction in Japanese Mmen. Hypertens Res 25:677–681
Keavney B, Danesh J, Parish S, Palmer A, Clark S, Youngman L, Delépine M, Lathrop M, Peto R, Collins R The International Studies of Infarct Survival (ISIS) Collaborators (2006) Fibrinogen and coronary heart disease: test of causality by ‘Mendelian randomization’. Int J Epidemiol 35:935–943
Thomas DC, Lawlor DA, Thompson JR (2007) Re: Estimation of bias in nongenetic observational studies using “Mendelian Triangulation”. Ann Epidemiol 17:511–513
Thun MJ, Peto R, Lopez AD (1997) Alcohol consumption and mortality among middle-aged and elderly US adults. New Engl J Med 337:1705–1714
Timpson NJ, Lawlor DA, Harbord RM, Gaunt TR, Day INM, Palmer LJ, Hattersley AT, Ebrahim S, Lowe GDO, Rumley A, Davey Smith G (2005) C-reactive protein and its role in metabolic syndrome: mendelian randomization study. Lancet 366:1954–1959
Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ et al (2004) Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 294:565–575
Tybjaerg-Hansen A, Humphries SE (1992) Familial defective apolipoprotein B-100: a single mutation that causes hypercholesterolemia and premature coronary artery disease. Atherosclerosis 96:91–107
Tybjærg-Hansen A, Steffenson R, Meinertz H, Schnohr P, Nordestgaard BG (1998) Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease. New Engl J Med 338:1577–1584
Van der Bom JG, De Maat MPM, Bots ML, Haverkate F, De Jong PTVM, Hofman A, Kluft C, Grobbee DE (1998) Elevated plasma fibrinogen. Cause or consequence of cardiovascular disease? Arterioscler Thromb Vasc Biol 18:621–625
Wald DS, Law M, Morris JK (2002) Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 325:1202–1206
Weimer RE (1973) Dissociation of phenotypic correlation: response to posttrial etherization and to temporal distribution of practice trials. Behav Genet 3:379–386
Wellcome Trust Case Control Consortium (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447:661–678
West-Eberhard MJ (2003) Developmental plasticity and evolution. Oxford University Press, Oxford
Wheatley K, Gray R (2004) Commentary: Mendelian randomization—an update on its use to evaluate allogeneic stem cell transplantation in leukaemia. Int J Epidemiol 33:15–17
Williams RS, Wagner PD (2000) Transgenic animals in integrative biology: approaches and interpretations of outcome. J Appl Physiol 88:1119–1126
Wolf U (1995) The genetic contribution to the phenotype. Hum Genet 95:127–148
Youngman LD, Keavney BD, Palmer A et al (2000) Plasma fibrinogen and fibrinogen genotypes in 4685 cases of myocardial infarction and in 6002 controls: test of causality by “Mendelian randomization”. Circulation 102(suppl II):31–32
Zeggini E, Weedon MN, Lindgren CM, Frayling TM, Elliott KS, Lango H et al (2007) Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316:1336–1341
Zoccali C, Testa A, Spoto B, Tripepi G, Mallamaci F (2006) Mendelian randomization: a new approach to studying epidemiology in ESRD. Am J Kidney Dis 47:332–341
Zuckerkandl E, Villet R (1988) Concentration—affinity equlivalence in gene regulation: convergence and environmental effects. Proc Natl Acad Sci USA 85:4784–4788
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ebrahim, S., Davey Smith, G. Mendelian randomization: can genetic epidemiology help redress the failures of observational epidemiology?. Hum Genet 123, 15–33 (2008). https://doi.org/10.1007/s00439-007-0448-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00439-007-0448-6